Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01209598
First received: September 24, 2010
Last updated: February 8, 2017
Last verified: February 2017